Both in Pharmaceuticals
Lakewood-Amedex Biotherapeutics vs PMGC Holdings
Over the past year LABT returned −86.0% and ELAB returned −40.1%; their daily moves had a correlation of -0.06.
LABT −86.0% ELAB −40.1%Growth of $1, one year, split-adjusted
| Metric | LABT | ELAB |
|---|---|---|
| Price | $0.3100 | $2.71 |
| Market cap | $734.6K | $2.2M |
| Today | −36.67% | +1.72% |
| 1 month | −83.0% | −40.1% |
| 6 months | — | −89.1% |
| Year to date | — | −99.2% |
| 1 year | — | −99.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 29.5% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.8× |
| Net cash | $4.6M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | — | 676.7% |
| Short % of float | 8.4% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).